Vivo Capital, LLC Q3 2017 Filing
Filed November 13, 2017
Portfolio Value
$494.8B
Holdings
29
Report Date
Q3 2017
Filing Type
13F-HR
All Holdings (29 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —Biohaven Pharmaceutical Holding Company Ltd | 1,976,818 | $73.9B | 14.93% | |
| 2 | ACRSAclaris Therapeutics | 2,858,569 | $73.8B | 14.91% | |
| 3 | ASNDAscendis Pharma | 1,766,832 | $64.0B | 12.94% | |
| 4 | —Nabriva Therapeutics PLC | 4,074,190 | $33.4B | 6.74% | |
| 5 | KALAKala Pharmaceuticals Inc. | 1,158,911 | $26.5B | 5.35% | |
| 6 | VRNAVerona Pharma Plc | 1,492,951 | $22.9B | 4.63% | |
| 7 | —Strongbridge Biopharma plc | 2,962,645 | $20.4B | 4.13% | |
| 8 | SELBUSDSelecta Biosciences, Inc. | 1,119,189 | $20.4B | 4.13% | |
| 9 | CDXSCodexis, Inc. | 3,054,825 | $20.3B | 4.11% | |
| 10 | CLDNEUREiger BioPharmaceuticals | 1,787,091 | $19.7B | 3.97% | |
| 11 | —Aimmune Therapeutics, Inc. | 776,813 | $19.3B | 3.89% | |
| 12 | —Advanced Accelerator Applications S.A. | 249,241 | $16.9B | 3.41% | |
| 13 | —Kadmon Holdings, Inc. | 3,333,333 | $11.2B | 2.26% | |
| 14 | AMRSEURAmyris | 2,826,711 | $9.0B | 1.83% | |
| 15 | ZLABZai Lab | 325,000 | $8.8B | 1.77% | |
| 16 | —Soleno Therapeutics, Inc. | 14,695,264 | $7.6B | 1.54% | |
| 17 | AUPHAurinia Pharmaceuticals Inc. | 1,213,290 | $7.6B | 1.54% | |
| 18 | —Agile Therapeutics, Inc. | 1,513,975 | $6.8B | 1.36% | |
| 19 | RGNXRegenxbio Inc. | 164,403 | $5.4B | 1.09% | |
| 20 | —Foamix Pharmaceuticals Ltd. | 855,000 | $4.7B | 0.96% | |
| 21 | —Trevena, Inc. | 1,728,000 | $4.4B | 0.89% | |
| 22 | —BioPharmX Corporation | 14,096,338 | $4.0B | 0.81% | |
| 23 | —Sierra Oncology, Inc | 2,438,270 | $3.8B | 0.76% | |
| 24 | CRSPCRISPR Therapeutics AG | 148,878 | $2.7B | 0.54% | |
| 25 | RVNCEURReVance Therapeutics, Inc. | 77,373 | $2.1B | 0.43% | |
| 26 | —Akari Therapeutics Plc | 345,850 | $2.1B | 0.43% | |
| 27 | KALVKalVista Pharmaceuticals, Inc. | 300,325 | $2.0B | 0.41% | |
| 28 | —Sunesis Pharmaceuticals, Inc. | 500,000 | $970.0M | 0.20% | |
| 29 | —Soleno Therapeutics, Inc. (W) | 943,858 | $112.0M | 0.02% |